Cognitive Peptides — Neurotrophic, Anxiolytic, and Sleep Research

Three Dimensions of Brain Research

The OSYRIS Cognitive category contains three compounds that address three fundamentally different dimensions of neurological function:

These aren't competing compounds — they address separate aspects of brain biology. A brain needs all three: the capacity to grow and adapt (neuroplasticity), the ability to regulate anxiety and stress (inhibitory control), and high-quality sleep (the state in which consolidation and maintenance occur).

Semax: Building the Brain's Capacity

Semax's research profile centers on neurotrophic factor upregulation — specifically BDNF and NGF. These proteins support the survival, growth, and differentiation of neurons. They are the brain's construction and maintenance crew.

What makes Semax unique among nootropics: Most nootropics modulate what neurons do in the moment (neurotransmitter levels, receptor sensitivity). Semax promotes the structural capacity of neurons — their ability to form new connections, maintain existing ones, and survive injury. This is a deeper level of brain biology than synapse-level modulation.

Research highlights: BDNF upregulation in hippocampus and cortex (Dolotov 2006), neuroprotection in ischemia models (infarct volume reduction), gene expression modulation of hundreds of genes, Russian clinical approval for neurological indications.

Best for: Neuroplasticity research, neuroprotection studies, BDNF biology, stroke models, transcriptomic neuroscience.

→ Semax Research Overview

Selank: Regulating the Brain's Brakes

Selank addresses the opposite dimension from Semax: inhibitory neurotransmission and anxiety regulation. While Semax promotes neural growth and activation, Selank enhances GABA-mediated inhibition — the brain's braking system that prevents overactivation.

What makes Selank unique among anxiolytics: It modulates GABA-A receptor subunit gene expression rather than directly binding the receptor. This gene-level intervention may explain why Selank doesn't produce the tolerance, dependence, and withdrawal associated with benzodiazepines.

The immune bonus: Selank's tuftsin heritage gives it immunomodulatory properties — an unexpected dual profile that makes it a tool for studying neuroimmunology.

Best for: Anxiolytic mechanism research, GABA-A receptor biology, non-benzodiazepine anxiolysis, neuroimmune studies, serotonin turnover research.

→ Selank Research Overview → Semax vs Selank Comparison

DSIP: The Sleep Dimension

DSIP fills a gap that Semax and Selank leave unaddressed: sleep biology. Sleep quality is fundamental to both neuroplasticity (memory consolidation occurs during sleep) and anxiety regulation (sleep disruption exacerbates anxiety). DSIP targets the architecture of sleep itself — the staging and quality of sleep cycles.

What makes DSIP different from sedatives: DSIP modulates sleep structure (increasing slow-wave delta sleep) without producing forced sedation. It influences sleep quality rather than sleep quantity — a more nuanced approach than hypnotic drugs.

Research context: Originally discovered in 1977 from the brains of sleeping rabbits. Variable results in human studies. Neuroendocrine modulatory effects (ACTH, cortisol, opioid system). Stress-adaptive properties in animal models.

Best for: Sleep architecture research, circadian biology, stress-sleep interaction studies, neuroendocrine modulation.

The Three Together: A Complete Cognitive Research Framework

Semax, Selank, and DSIP address the three pillars of brain health: growth (neuroplasticity), regulation (anxiety control), and maintenance (sleep). Researchers studying cognition comprehensively can use all three to investigate how these dimensions interact:

• Does enhanced neuroplasticity (Semax/BDNF) depend on sleep quality (DSIP) for consolidation?
• Does anxiety reduction (Selank/GABA) improve neuroplasticity outcomes?
• Does improved sleep architecture affect daytime cognitive measures?

These interaction questions represent the frontier of cognitive neuroscience — and the OSYRIS Cognitive category provides the pharmacological tools to investigate them.

Cross-Category Connections

• NAD+ (Longevity) has neuroprotective research and crosses into cognitive biology through sirtuin-mediated gene regulation in neurons
• VIP (Immune) is a neuropeptide with CNS distribution relevant to circadian rhythm and neuroprotection
• PT-141 (Hormonal) acts through central melanocortin receptors and has behavioral research applications